Abstract
Highlight (Word Count: 49):
We conducted contact-tracing investigation of multiple patients and healthcare workers exposed to a pre-symptomatic physician, triple-vaccinated with BNT162b2 COVID-19 vaccine, infected with SARS-CoV-2 B.1.1.529 (Omicron) Variant. Of 51 contacts, 45(88%) were triple-vaccinated (boosted) with BNT162b2 vaccine and 47(92%) contacts were masked. One (1/51, 2%) triple-vaccinated primary contact became infected.
Keywords: BNT162B2, COVID-19 vaccine, Travel, Israel, Omicron variant, SARS-CoV-2 B.1.1.529 variant
Supplementary Material
20220113_1315_Omicron_Online_Appendix_R1_taac003
Click here for additional data file. (15.1KB, docx)
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
20220113_1315_Omicron_Online_Appendix_R1_taac003
Click here for additional data file. (15.1KB, docx)